NXL Nexalin Technology Forecast, Technical & Fundamental Analysis
Nexalin Technology Inc designs and develops neurostimulation products and bioelectronic medical technology to treat anxiety and insomnia without drugs or psychotherapy... Show more
NXL is expected to report earnings to fall 9.09% to -10 cents per share on September 02
Q2'26
Est.
$-0.10
Q1'26
Beat
by $0.01
Q4'25
Missed
by $0.01
Q3'25
Missed
by $0.01
Q2'25
Beat
by $0.04
The last earnings report on May 08 showed earnings per share of -10 cents, beating the estimate of -11 cents. With 45.10K shares outstanding, the current market capitalization sits at 7.44M.
A.I.dvisor indicates that over the last year, NXL has been loosely correlated with PFSA. These tickers have moved in lockstep 33% of the time. This A.I.-generated data suggests there is some statistical probability that if NXL jumps, then PFSA could also see price increases.
Momentum Indicator for NXL turns negative, indicating new downward trend
NXL saw its Momentum Indicator move below the 0 level on July 28, 2026. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 65 similar instances where the indicator turned negative. In of the 65 cases, the stock moved further down in the following days. The odds of a decline are at .
Technical Analysis (Indicators)
Bearish Trend Analysis
The Moving Average Convergence Divergence Histogram (MACD) for NXL turned negative on July 28, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 28 similar instances when the indicator turned negative. In of the 28 cases the stock turned lower in the days that followed. This puts the odds of success at .
NXL moved below its 50-day moving average on July 28, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for NXL crossed bearishly below the 50-day moving average on July 31, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In of 13 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where NXL declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
The Aroon Indicator for NXL entered a downward trend on July 10, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Bullish Trend Analysis
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where NXL's RSI Oscillator exited the oversold zone, of 33 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .
The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where NXL advanced for three days, in of 167 cases, the price rose further within the following month. The odds of a continued upward trend are .
NXL may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.576) is normal, around the industry mean (10.948). P/E Ratio (0.000) is within average values for comparable stocks, (63.950). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (4.043). NXL has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.016). P/S Ratio (22.075) is also within normal values, averaging (35.779).
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. NXL’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. NXL’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.
